"... there is a great chance this company will fail."
What makes you say that? Great clinical results. Geert says that there already are biotechs that want to collaborate. Stronger pipeline than some biotechs with 20 times the market cap. Enough cash for a year--plenty of time to develop to point of being a buyout target.
Why do you think there is a great chance that this company will fail? I would like to hear what you have to say on this matter, because I just don't see it that way.
I am sure that there were lots of discouraged, disgruntled KBIO shareholders that just gave up right before the jump from less than a dollar to $18. No doubt there were lots of wise guys saying that KBIO is "joke" etc.
To let one's discouragement with the price of Rxi cause them to sell now would be a shame and is unnecessary. We are priced as if we are ready to just fade away. That simply won't happen.
"I don't think we'll have to wait too long if they are aggressive on pushing the cosmetic product pipeline angle."
I look at it a little differently. The longer they wait to partner any of the targets--i.e. the less aggressive they are now in getting a deal--the better the deals will be when finally made.
As long as the clinical results continue to look good, I see lots of upside in waiting quite a while to partner, and no downside.
Go to the website Stockcharts and pull up the chart for KBIO. You will see that it went in four days from less than $1 to a high today of $24, and closed today at $18.
I am not saying or predicting that precisely that scenario will be repeated for RXII. I am saying that a very big jump in the price of RXII could happen fairly suddenly--and will happen when and if the conditions are right. It is way under-appreciated and underpriced.
I have been buying the beejuzus out of RXII recently and now have more shares than I ever dreamed of having. Unless everything absolutely falls apart fundamentally, it is difficult to see how RXII will be at less than $10 a year from now--unless it is bought out first.
Do your own due diligence and see if you disagree.
"I should short WNR to lock in the discount, if there's borrow available. But I'm not that smart."
You are definitely that smart. I should be as smart!
Shorts who post lies over and over again are, indeed, #$%$. But longs who post lies over and over again are also #$%$. Short attacks accompanied by lies are despicable things. Pump and dump schemes that are accompanied by lies are also despicable things.
There is (as far as I can see) nothing inherently immoral about shorting. What is immoral is the lying that sometimes accompanies shorting.
"You don't know anything about TA anyway"
Oh? Is that right? Golden Cross=50dma crossing above 200dma. Golden Cross "forming" is not a technical term; however, to give you the benefit of the doubt, let us say that a Golden Cross is forming when the 50dma is about to cross over the 200dma, or is nearing the 200dma. Nothing like that is going on. We are in a congestion zone. .40 has been acting as strong resistance lately. The 200dma is barely visible on a 6 mo. chart because it is way north of the current price channel.
Maybe you mean by "forming" that you believe the price will move up to the point at which the 50dma crosses above the 200dma. Well, maybe it will--and maybe it will drop below the all time low of .34. In any case there is nothing about the technicals--about the chart--that shows or says or suggests that a Golden Cross is going to happen.
Technical analysis has nothing to do with what you think, or wish, or want to happen. It is merely a reading of the current situation and the trends and judging from those what will likely happen. I realize, hangon, that you want the price to go up. So do I. That doesn't mean that the technicals, the chart, say it probably will.
Ranting and raving and insulting others does not mean that your hope will come true. It might but there is nothing about the current chart that says the Golden Cross will occur.
I have noticed a spate of posts saying that shorts are evil and should die horrible deaths, blah, blah, blah. Why? Shorts believe a stock is overpriced and that they can capitalize on that. We are all trying to make money. Why shouldn't there be a way for those who believe a stock is overpriced to try to capitalize on that belief?
As I see it, longs and shorts are just trying to better themselves by acting in a way they think will make them money. Some say shorting shouldn't be allowed. Why?
Anyway, as I said in another post, there are likely no shorts posting on this board. A short position is a margin position and ordinary, individual investors cannot normally take a margin position in a stock under $3 or so--only hedge funds, markets makers and such can do that.
Ranting and raving at "shorts" on this board is just plain silly. Avi, mickfoolish, etc. are not shorts. They are simply people who like to needle and annoy longs. Taking them too seriously will just give you ulcers and play into their silly game. They need to get a life but we don't need to give them any attention.
Face it, this stock will move when and if big money players decide it is a good buy. Until and unless that happens the price will not go up much. Shorts (such as there are, viz. market makers, hedge funds, etc.) just take advantage of the lack of current interest in Rxi Pharma.
"Longs can't ever lose more than what they've invested."
That is simply false. When you buy a stock on margin, you stand to lose a lot more than the cash you put up. I know, unfortunately, because it has happened to me more than once.
Of course, none of us are currently buying RXII on margin because no retail broker will sell us a $.40 stock on margin. By the same token, none of us are shorting it anywhere near here because no retail broker will allow ordinary investors to short a stock well below $1. [By the way, all the postings here who accuse the negative posters of being short are silly. Some hedge funds and market makers are short but nobody who posts here is--unless he/she is a shill for a hedge fund, which I seriously doubt.]
Golden Cross has a ways to go. Golden Cross=50dma crossing above 200dma. The 200dma is currently just above .60. That's more than 50% above where we are now.
It is nice to be bullish but to talk about a Golden Cross as if it were imminent when it is 50% above the current price is a bit much. We are still a lot, lot closer to the all time low than we are to the Golden Cross.
Well, I think he wants to hold off even on licensing deals as long as he can. The more validation he has on the technology, the juicier the licensing deal a big pharma will give him. At least that's how it appears.
From the cc on cosmeceutical collaboration: "So our intention is to bring it up to a certain point, and while we are doing that, also negotiating with those potential partners to see if we can come to a collaboration so that those potential partners would take some of the work out of our hands." I think that is the strategy not only on cosmeceuticals but on other things as well.
He wants to bring the research "...up to a certain point" before cutting any big deals. The longer he can wait and the more development he can do internally, the bigger the deals. Makes sense to me.
I dunno why there is no insider buying--and Geert hasn't bought since April. Weird I say.
I also see that there are still still 5 million+ short shares as of Oct. 30 (last report)--essentially the same as the Oct. 15 report. Call me crazy but I wouldn't want to be short this stock right now.
Hard to tell if there has been covering and re-shorting, or just sitting on the previous short positions.
We are a nickel from the all-time low. Nothing but good news has been pouring out and, yet, the plunge has been unabated. Promises of deals--or, at least, very strong hints that deals are in discussion--have been made for many months, but nothing. We are way too low in price for an equity raise and we do not exactly have a comfortable cash cushion. At this level, it becomes difficult for other biotechs to justify juicy deals because they have to go against all investor sentiment.
I still believe in Rxi Pharma and have been buying. I will say, however, that Geert has his work cut out for him.
The volume is so extraordinarily light that I don't think it is tax loss selling. If it is, nevertheless, tax loss selling of a small number of shares that doesn't explain why there are no buyers at all. Late November should be a good time to go after stocks that are near their all time lows and that have a good fundamental situation. Why would those interested in RXII not be buying when it is under .40?
The lack of buying interest just isn't explained in terms of tax loss selling, imo.
The low volume and the drift down of the price is surprising. I can't understand why nobody wants this at the moment. Nevertheless, it is impossible to believe, after Geert's recent cc and all that has been accomplished and all the interest Geert reported by other companies, that this will stay down here much longer. I am still buying, even though I have more of this now than I ever dreamed I would have.
For me, the stupidly low market price has been a fortunate thing, it has enabled me to get enough shares to someday make millions on this stock.
No rush to the exits by longs. I doubt that there is any shorting. There is, on the other hand, no buying interest today either. Dunno what gives.